Labo Euromedis (STU:61R) FCF Margin %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:61R Labo Euromedis STU:61R
68 GF Score
Price €4.88
GF Value €4.39
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Labo Euromedis FCF Margin %?

Labo Euromedis STU:61R +2.95% 68 FCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates STU:61R with a GF Score™ of 68/100 and a GF Value™ of €4.39 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 115 Medical Distribution companies, Labo Euromedis ranks worse than 869564.35% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Labo Euromedis's Free Cash Flow for the six months ended in Dec. 2025 was €0.00 Mil. Labo Euromedis's Revenue for the six months ended in Dec. 2025 was €20.40 Mil. Therefore, Labo Euromedis's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Labo Euromedis's current FCF Yield % is 0.00%.

The historical rank and industry rank for Labo Euromedis's FCF Margin % or its related term are showing as below:


During the past 13 years, the highest FCF Margin % of Labo Euromedis was 15.56%. The lowest was -3.84%. And the median was 0.12%.

STU:61R's FCF Margin % is not ranked *
in the Medical Distribution industry.
Industry Median: 0.97
* Ranked among companies with meaningful FCF Margin % only.

Labo Euromedis FCF Margin % Related Terms

Labo Euromedis FCF Margin % Historical Data

* Premium members only.

The historical data trend for Labo Euromedis's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labo Euromedis FCF Margin % Chart

Labo Euromedis Annual Data
Trend Jul15 Jul16 Jul17 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.56 -3.84 0.00 0.00 0.00

Labo Euromedis Semi-Annual Data
Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 4.24 0.00 0.00 0.00

STU:61R vs MCK, CAH, COR: FCF Margin % Comparison

For the Medical Distribution subindustry, Labo Euromedis's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Labo Euromedis FCF Margin % vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Labo Euromedis's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Labo Euromedis's FCF Margin % falls into.


STU:61R
68GF Score
Labo Euromedis STU:61R
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Labo Euromedis FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Labo Euromedis's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=0/40.848
=0.00 %

Labo Euromedis's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0/20.399
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Labo Euromedis (STU:61R) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Labo Euromedis and its competitors. According to the industry distribution chart, Labo Euromedis ranks #999999 out of 115 companies in the Medical Distribution industry.
Is Labo Euromedis' FCF Margin % too high?
Labo Euromedis' current FCF Margin % is 0.00%. Based on the distribution chart, Labo Euromedis ranks #999999 out of 115 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Labo Euromedis has a GF Score™ of 68/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Labo Euromedis' FCF Margin % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Labo Euromedis ranks #999999 out of 115 companies for FCF Margin %. This places Labo Euromedis in the lower half of its industry. The industry median FCF Margin % is 0.97. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Distribution company?
The median FCF Margin % among Medical Distribution companies is 0.97, based on 115 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Labo Euromedis and its competitors. For the Medical Distribution industry, the median FCF Margin % is 0.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Labo Euromedis's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labo Euromedis stock overvalued right now?
Based on GuruFocus' analysis, Labo Euromedis (STU:61R) is currently considered Modestly Overvalued. The stock's GF Value™ is €4.39, compared to a current price of €4.88 — trading 11.2% above its estimated fair value. The current FCF Margin % is 0.00%. Labo Euromedis' overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Labo Euromedis (STU:61R), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Labo Euromedis (STU:61R) Overvalued in 2026?

Based on GuruFocus' analysis, Labo Euromedis stock appears to be overvalued. The current stock price of €4.88 is trading 11.2% above its estimated GF Value™ of €4.39. GuruFocus considers Labo Euromedis to be Modestly Overvalued.

Key valuation signals for STU:61R:

  • FCF Margin %: 0.00%
  • GF Value™: €4.39 vs. price of €4.88 (11.2% above fair value)
  • GF Score™: 68/100 with 6 warning signs

No single metric tells the full story. See the STU:61R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Labo Euromedis Business Description

Other Exchanges 0I0L:UKALEMG:France
Address ZI de la Tuilerie, Neuilly-sous-Clermont, FRA, 60290
Labo Euromedis is engaged in medical devices. It is engaged in the design, manufacture, rental and export of medical and surgical equipment and products.
68GF Score

Get the complete analysis for STU:61R

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.88
Price
€4.39
GF Value